Mycronic 配当と自社株買い
配当金 基準チェック /06
Mycronic配当を支払う会社であり、現在の利回りは1.01%です。
主要情報
1.0%
配当利回り
0.03%
バイバック利回り
| 総株主利回り | 1.0% |
| 将来の配当利回り | 1.6% |
| 配当成長 | 12.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | 37% |
最近の配当と自社株買いの更新
Recent updates
MYCR: Upgraded Rating And Raised Guidance Will Eventually Confront Rich Pricing
Analysts have lifted their price target for Mycronic to SEK 385, with an implied fair value move from SEK 211 to SEK 230. This reflects updated assumptions on discount rate, revenue growth, profit margin and future P/E, and it aligns with recent Street research where the stock was upgraded to Buy.MYCR: Upgraded Rating And 2026 Guidance Will Drive Revaluation Potential
Analysts have raised their price target on Mycronic from SEK 320 to SEK 385, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Mycronic Mycronic issued updated guidance for 2026.MYCR: Higher Guidance And Orders Will Face Lower Margin Pressure
Analysts have lifted their price target for Mycronic from SEK 161 to SEK 211, citing updated assumptions on growth, margins and P/E multiples, along with recent supportive Street research that includes a SEK 385 target. What’s in the News for Mycronic Mycronic received an SLX mask writer order from an existing customer in Asia, valued between US$5 million and US$7 million, with delivery planned for the second quarter of 2027.MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.MYCR: Cautious Ratings And New Orders Will Shape Execution Focus
The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.MYCR: Sector Downgrades And Execution Risks Will Restrain Future Upside
The latest Narrative Update on Mycronic reflects a reduced analyst price target of SEK260.25, as analysts factor in slightly lower revenue growth and profit margin assumptions, along with a modestly higher future P/E, in the context of several recent downgrades on the stock. Analyst Commentary Recent research on Mycronic points to a more cautious stance among several bearish analysts, who have downgraded the stock while reassessing revenue growth, margins, and valuation multiples.Mycronic (OM:MYCR) Stock Could Be 17.2% Overvalued After New SLX Order
Mycronic (OM:MYCR) stock is back in focus after the company reported a new European customer order for its SLX laser mask writer, valued at US$6 to 8 million with delivery planned in Q3 2026. See our latest analysis for Mycronic. The SLX order lands at a time when Mycronic’s short term share price momentum has been firm, with a 90 day share price return of 44.34%. The 1 year total shareholder return of 70.93% and 3 year total shareholder return of 151.03% point to strong long term...MYCR: Sector Downgrades And Higher Risk Perceptions Will Pressure Future Upside
Analysts have trimmed their stance on Mycronic, nudging the SEK 260.25 price target lower in line with a slightly higher discount rate and more cautious sector views following several recent rating downgrades. Analyst Commentary Recent research has taken a more cautious tone on Mycronic, with several downgrades pointing to higher required returns and more conservative sector assumptions feeding into valuation work.MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside
The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside
Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile
Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook
Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook
Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook
Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook
Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook
Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook
Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects
Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025
Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Upcoming Orders and Expansion Will Drive Global Technology Reach Forward
Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.Acquisitions And Launches Will Expand Global Technology Reach
Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...Acquisitions And Launches Will Expand Global Technology Reach
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.Historically Cheap, but the Margin of Safety Is Still Thin
Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directly決済の安定と成長
配当データの取得
安定した配当: MYCRはSwedish市場で注目すべき配当金を支払っていないため、支払いが安定しているかどうかを確認する必要はありません。
増加する配当: MYCRはSwedish市場で注目すべき配当金を支払っていないため、支払額が増加しているかどうかを確認する必要はありません。
配当利回り対市場
| Mycronic 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (MYCR) | 1.0% |
| 市場下位25% (SE) | 1.7% |
| 市場トップ25% (SE) | 4.3% |
| 業界平均 (Electronic) | 1.5% |
| アナリスト予想 (MYCR) (最長3年) | 1.6% |
注目すべき配当: MYCRの配当金 ( 1.01% ) はSwedish市場の配当金支払者の下位 25% ( 1.69% ) と比べると目立ったものではありません。
高配当: MYCRの配当金 ( 1.01% ) はSwedish市場の配当金支払者の上位 25% ( 4.32% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: MYCR Swedish市場において目立った配当金を支払っていません。
株主配当金
キャッシュフローカバレッジ: MYCR Swedish市場において目立った配当金を支払っていません。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/09/14 08:04 |
| 終値 | 2026/09/11 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Mycronic AB (publ) 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9
| アナリスト | 機関 |
|---|---|
| Nils Sjogren | ABG Sundal Collier Sponsored |
| Oliver Wong | BofA Global Research |
| Mikael Laséen | Carnegie Investment Bank AB |